Min Zhang1,2, Zhen Wang1,2, Yongqiang Zhang1,2, Wenxing Guo1,2, Haitao Ji1,2. 1. Drug Discovery Department , H. Lee Moffitt Cancer Center and Research Institute , Tampa , Florida 33612 , United States. 2. Departments of Oncologic Sciences and Chemistry , University of South Florida , Tampa , Florida 33620 , United States.
Abstract
Structure-based optimization was conducted to improve the potency, selectivity, and cell-based activities of β-catenin/B-cell lymphoma 9 (BCL9) inhibitors based on the 4'-fluoro- N-phenyl-[1,1'-biphenyl]-3-carboxamide scaffold, which was designed to mimic the side chains of the hydrophobic α-helical hot spots at positions i, i + 3, and i + 7. Compound 29 was found to disrupt the β-catenin/BCL9 protein-protein interaction (PPI) with a Ki of 0.47 μM and >1900-fold selectivity for β-catenin/BCL9 over β-catenin/E-cadherin PPIs. The proposed binding mode of new inhibitors was consistent with the results of site-directed mutagenesis and structure-activity relationship studies. Cell-based studies indicated that 29 disrupted the β-catenin/BCL9 interaction without affecting the β-catenin/E-cadherin interaction, selectively suppressed transactivation of Wnt/β-catenin signaling, downregulated expression of Wnt target genes, and inhibited viability of Wnt/β-catenin-dependent cancer cells in dose-dependent manners. A comparison of the biochemical and cell-based assay results offered the directions for future inhibitor optimization.
Structure-based optimization was conducted to improve the potency, selectivity, and cell-based activities of β-catenin/B-cell lymphoma 9 (n class="Gene">BCL9) inhibitors based on the 4'-fluoro- N-phenyl-[1,1'-biphenyl]-3-carboxamide scaffold, which was designed to mimic the side chains of the hydrophobic α-helical hot spots at positions i, i + 3, and i + 7. Compound 29 was found to disrupt the β-catenin/BCL9 protein-protein interaction (PPI) with a Ki of 0.47 μM and >1900-fold selectivity for β-catenin/BCL9 over β-catenin/E-cadherin PPIs. The proposed binding mode of new inhibitors was consistent with the results of site-directed mutagenesis and structure-activity relationship studies. Cell-based studies indicated that 29 disrupted the β-catenin/BCL9 interaction without affecting the β-catenin/E-cadherin interaction, selectively suppressed transactivation of Wnt/β-catenin signaling, downregulated expression of Wnt target genes, and inhibited viability of Wnt/β-catenin-dependent cancer cells in dose-dependent manners. A comparison of the biochemical and cell-based assay results offered the directions for future inhibitor optimization.
Authors: James Sampietro; Caroline L Dahlberg; Uhn Soo Cho; Thomas R Hinds; David Kimelman; Wenqing Xu Journal: Mol Cell Date: 2006-10-20 Impact factor: 17.970
Authors: Felix H Brembeck; Thomas Schwarz-Romond; Jeroen Bakkers; Sabine Wilhelm; Matthias Hammerschmidt; Walter Birchmeier Journal: Genes Dev Date: 2004-09-01 Impact factor: 11.361
Authors: Michael L Huebschman; Nancy L Lane; Huaying Liu; Venetia R Sarode; Judith L Devlin; Eugene P Frenkel Journal: Breast Cancer (Dove Med Press) Date: 2015-08-11
Authors: Sylvie Maubant; Bruno Tesson; Virginie Maire; Mengliang Ye; Guillem Rigaill; David Gentien; Francisco Cruzalegui; Gordon C Tucker; Sergio Roman-Roman; Thierry Dubois Journal: PLoS One Date: 2015-04-07 Impact factor: 3.240
Authors: Peng Sang; Min Zhang; Yan Shi; Chunpu Li; Sami Abdulkadir; Qi Li; Haitao Ji; Jianfeng Cai Journal: Proc Natl Acad Sci U S A Date: 2019-05-14 Impact factor: 11.205
Authors: Michael A McCoy; Dominique Spicer; Neil Wells; Kurt Hoogewijs; Marc Fiedler; Matthias G J Baud Journal: J Med Chem Date: 2022-05-17 Impact factor: 8.039
Authors: Zhen Wang; Min Zhang; Victor Quereda; Sylvia M Frydman; Qianqian Ming; Vincent C Luca; Derek R Duckett; Haitao Ji Journal: J Med Chem Date: 2021-08-12 Impact factor: 8.039
Authors: Helen Tanton; Tomasz Sewastianik; Hyuk-Soo Seo; David Remillard; Roodolph St Pierre; Pratyusha Bala; Daulet Aitymbayev; Peter Dennis; Keith Adler; Ezekiel Geffken; Zoe Yeoh; Nicholas Vangos; Filip Garbicz; David Scott; Nilay Sethi; James Bradner; Sirano Dhe-Paganon; Ruben D Carrasco Journal: Sci Adv Date: 2022-04-29 Impact factor: 14.957
Authors: Sarah L Blosser; Nicholas Sawyer; Igor Maksimovic; Brahma Ghosh; Paramjit S Arora Journal: ACS Chem Biol Date: 2021-07-21 Impact factor: 4.634